Literature DB >> 10479670

Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture.

C Lupu1, E Poulsen, S Roquefeuil, A D Westmuckett, V V Kakkar, F Lupu.   

Abstract

Tissue factor pathway inhibitor (TFPI), the major downregulator of procoagulant activity of the tissue factor-factor VIIa complex (TF. FVIIa), is synthesized and constitutively secreted by endothelial cells (ECs). Here we describe the in vitro effects of heparin on the cellular localization, gene expression, and release of TFPI in human ECs in culture. Both unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH; Fragmin) time-dependently induced a significant enhanced secretion of TFPI, paralleled by a redistribution and increase of TFPI on the cell surface and a decrease of intracellular TFPI. Immunogold electron microscopy showed the presence of clusters of TFPI, both on the plasmalemma proper and within cell-surface opened caveolae/enlarged caveolar profiles. Activation of FX by TF. FVIIa on ECs treated with endotoxin was inhibited by both heparins but to a higher extent by LMWH. Inhibition of protein synthesis by cycloheximide did not reduce the release of TFPI induced by heparin. Long-term incubation (48 hours) resulted in a time-dependent enhanced production of TFPI. After the first 4 to 8 hours, depletion of intracellular TFPI was observed, more significantly with UFH. Northern blot analysis of TFPI mRNA also showed a decrease of the 1.4-kb transcript after 4 hours of incubation with UFH, followed by recovery and an increase over the control level after 24 hours. Incubation of ECs with phorbol ester (PMA) significantly enhanced the secretion of TFPI and increased its activity on the cell surface, probably by preventing invagination of caveolae. Heparin-stimulated release of TFPI decreased significantly in the presence of PMA to a level that was 2. 4 times lower than the expected additive value for PMA and UFH separately. Pretreatment of ECs with PMA suppressed a subsequent response to heparin. Altogether, our results suggest that the heparin-induced release of TFPI might involve a more specific mechanism(s) than the previously hypothesized simple displacement of TFPI from the cell surface glycocalyx. We assume that the increased secretion and redistribution of cellular TFPI induced by heparins in ECs in culture can play an important role in the modulation of the anticoagulant properties of the endothelium.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10479670     DOI: 10.1161/01.atv.19.9.2251

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  26 in total

1.  TFPIβ is the GPI-anchored TFPI isoform on human endothelial cells and placental microsomes.

Authors:  Thomas J Girard; Elodee Tuley; George J Broze
Journal:  Blood       Date:  2011-12-05       Impact factor: 22.113

2.  Vascular endothelial tissue factor pathway inhibitor kinetics in culture following exposure to DX-9065a--a selective and direct factor Xa inhibitor.

Authors:  Richard C Becker; John H Alexander; Youfu Li; Thomas Robertson; Satoshi Kunitada; Frederick A Spencer; Hongqiu Yang; Robert A Harrington
Journal:  J Thromb Thrombolysis       Date:  2004-12       Impact factor: 2.300

3.  Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function.

Authors:  Marybeth Langer; Elizabeth Stewart Duggan; John Leland Booth; Vineet Indrajit Patel; Ryan A Zander; Robert Silasi-Mansat; Vijay Ramani; Tibor Zoltan Veres; Frauke Prenzler; Katherina Sewald; Daniel M Williams; Kenneth Mark Coggeshall; Shanjana Awasthi; Florea Lupu; Dennis Burian; Jimmy Dale Ballard; Armin Braun; Jordan Patrick Metcalf
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

4.  Factor VII-activating protease promotes the proteolysis and inhibition of tissue factor pathway inhibitor.

Authors:  Sandip M Kanse; Paul J Declerck; Wolfram Ruf; George Broze; Michael Etscheid
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-23       Impact factor: 8.311

5.  Novel protein ADTRP regulates TFPI expression and function in human endothelial cells in normal conditions and in response to androgen.

Authors:  Cristina Lupu; Hua Zhu; Narcis I Popescu; Jonathan D Wren; Florea Lupu
Journal:  Blood       Date:  2011-08-25       Impact factor: 22.113

6.  Tissue factor-dependent coagulation is preferentially up-regulated within arterial branching areas in a baboon model of Escherichia coli sepsis.

Authors:  Cristina Lupu; Andrew D Westmuckett; Glenn Peer; Lacramioara Ivanciu; Hua Zhu; Fletcher B Taylor; Florea Lupu
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

7.  Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin.

Authors:  Shaker A Mousa; Robert Linhardt; John L Francis; Ali Amirkhosravi
Journal:  Thromb Haemost       Date:  2006-12       Impact factor: 5.249

8.  Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistance.

Authors:  YouFu Li; Miguel Rodriquez; Frederick A Spencer; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2002-10       Impact factor: 2.300

Review 9.  Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases.

Authors:  Bernhard F Becker; Matthias Jacob; Stephanie Leipert; Andrew H J Salmon; Daniel Chappell
Journal:  Br J Clin Pharmacol       Date:  2015-05-22       Impact factor: 4.335

Review 10.  Biology of tissue factor pathway inhibitor.

Authors:  Jeremy P Wood; Paul E R Ellery; Susan A Maroney; Alan E Mast
Journal:  Blood       Date:  2014-03-11       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.